Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Rose

Showing results (31-40 of 201) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Role of surgery in ovarian carcinomaAmanda Nickles Fader, Peter G Rose
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2009
Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxelAmanda N Fader, Peter G Rose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Chemoradiation for locally advanced cervical cancer: does it help?Peter G Rose, Brian N Bundy
Anti-Cancer Drugs|May 26, 2017
Long-term use of pegylated liposomal doxorubicin to a cumulative dose of 4600 mg/m2 in recurrent ovarian cancerAdam Pendlebury, Robert DeBernardo, Peter G Rose
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 20, 2015
Outcome of recurrent uterine papillary serous carcinoma treated with platinum-based chemotherapyHaider Mahdi, Anthony Rizzo, Peter G Rose
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 12, 2014
Desensitization with oxaliplatin in patients intolerant of carboplatin desensitizationPeter G Rose, Carol Metz, Nicolas Link
Journal of Surgical Oncology|February 16, 2021
Surgical lymph node assessment influences adjuvant therapy in clinically apparent stage I endometrioid endometrial carcinoma, meeting Mayo criteria for lymphadenectomyAdam Pendlebury, Milena Radeva, Peter G Rose
Anti-Cancer Drugs|April 12, 2019
Reduction in skin and mucosal toxicity with pegylated liposomal doxorubicin utilizing every 2-week dosingPeter G Rose, Denise Purpura, Lisa Petersen
Gynecologic Oncology|January 22, 2005
A phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinomaPeter G Rose, Mary Smrekar, Nancy Fusco
Current Opinion in Oncology|August 12, 2005
Management of locally advanced cervical cancerLuis A Rojas-Espaillat, Peter G Rose
Pageof 21

Showing results (31-40 of 201) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Role of surgery in ovarian carcinomaAmanda Nickles Fader, Peter G Rose
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2009
Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxelAmanda N Fader, Peter G Rose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Chemoradiation for locally advanced cervical cancer: does it help?Peter G Rose, Brian N Bundy
Anti-Cancer Drugs|May 26, 2017
Long-term use of pegylated liposomal doxorubicin to a cumulative dose of 4600 mg/m2 in recurrent ovarian cancerAdam Pendlebury, Robert DeBernardo, Peter G Rose
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 20, 2015
Outcome of recurrent uterine papillary serous carcinoma treated with platinum-based chemotherapyHaider Mahdi, Anthony Rizzo, Peter G Rose
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 12, 2014
Desensitization with oxaliplatin in patients intolerant of carboplatin desensitizationPeter G Rose, Carol Metz, Nicolas Link
Journal of Surgical Oncology|February 16, 2021
Surgical lymph node assessment influences adjuvant therapy in clinically apparent stage I endometrioid endometrial carcinoma, meeting Mayo criteria for lymphadenectomyAdam Pendlebury, Milena Radeva, Peter G Rose
Anti-Cancer Drugs|April 12, 2019
Reduction in skin and mucosal toxicity with pegylated liposomal doxorubicin utilizing every 2-week dosingPeter G Rose, Denise Purpura, Lisa Petersen
Gynecologic Oncology|January 22, 2005
A phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinomaPeter G Rose, Mary Smrekar, Nancy Fusco
Current Opinion in Oncology|August 12, 2005
Management of locally advanced cervical cancerLuis A Rojas-Espaillat, Peter G Rose
Pageof 21